Clinical Trial Update: Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update exploring optimized induction chemotherapy and concurrent chemoradiotherapy with reduced treatment intensity for nasopharyngeal carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Nasopharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Stage II, III, Nasopharyngeal Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN